A role for ACE2 is emerging in Alzheimer disease, since it has been shown that ACE2 can hydrolyse Beta amyloid peptides (Zou et al., 2007, 2013). This evidence concerns the gene ACE2 and early-onset autosomal dominant Alzheimer disease.